Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Leukemia
|
November 20, 2019
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry
Hanneke C Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, et al.
American Journal of Hematology
|
December 10, 2019
Second cancers in MPN: Survival analysis from an international study
Monia Marchetti, Arianna Ghirardi, Arianna Masciulli, et al.
Theranostics
|
January 4, 2021
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis
Hanneke C Kluin-Nelemans, Mohamad Jawhar, Andreas Reiter, et al.
Blood
|
December 27, 2019
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study
Simona Soverini, Luana Bavaro, Caterina De Benedittis, et al.
Oncotarget
|
September 1, 2016
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome
Alessandra Iurlo, Alessandro Nobili, Roberto Latagliata, et al.
Leukemia
|
September 21, 2021
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis
Roberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Leukemia
|
November 20, 2019
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry
Hanneke C Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, et al.
American Journal of Hematology
|
December 10, 2019
Second cancers in MPN: Survival analysis from an international study
Monia Marchetti, Arianna Ghirardi, Arianna Masciulli, et al.
Theranostics
|
January 4, 2021
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis
Hanneke C Kluin-Nelemans, Mohamad Jawhar, Andreas Reiter, et al.
Blood
|
December 27, 2019
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study
Simona Soverini, Luana Bavaro, Caterina De Benedittis, et al.
Oncotarget
|
September 1, 2016
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome
Alessandra Iurlo, Alessandro Nobili, Roberto Latagliata, et al.
Leukemia
|
September 21, 2021
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis
Roberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, et al.
Page
of 5